ULTRA PURE LPS from Escherichia coli O55:B5
#423
如果您對該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱: ULTRA PURE LPS from Escherichia coli O55:B5
#423
產(chǎn)品型號: #423
產(chǎn)品展商: 其他品牌
產(chǎn)品文檔: 無相關(guān)文檔
簡單介紹
Vaccine Carrier Proteins and Adjuvants
Large inactivated toxins such as tetanus toxoid, diphtheria toxoid and diphtheria CRM197 are used as carriers in vaccines to develop strong immune responses. Conjugate vaccines rely on these immunogenic molecules to stimulate long-lasting immunity to attached polysaccharides or peptides. List Labs provides, for purchase, formaldehyde inactivated native toxin
ULTRA PURE LPS from Escherichia coli O55:B5
#423
的詳細(xì)介紹
Vaccine Carrier Proteins and Adjuvants
Large inactivated toxins such as tetanus toxoid, diphtheria toxoid and diphtheria CRM197 are used as carriers in vaccines to develop strong immune responses. Conjugate vaccines rely on these immunogenic molecules to stimulate long-lasting immunity to attached polysaccharides or peptides. List Labs provides, for purchase, formaldehyde inactivated native toxins such as tetanus toxoid and diphtheria toxoid, as well as the natural mutant diphtheria toxin, CRM197, all potential carrier proteins and vaccine adjuvants. Recently List Labs has produced genetically altered pertussis toxin which retains some toxin activity and may be used as a carrier protein/vaccine adjuvant.
List Labs vaccine carrier proteins and adjuvants are provided for research use only; however, GMP material may be produced on a contract basis. Contact us if you are interested in GMP production or in using toxoids of other native toxins as carriers or vaccine adjuvants.
Our Citations include information referencing the use of vaccine carrier proteins in research.
Our Support Portal provides technical information on our vaccine carrier products.
Visit our blog to learn more about what we do.
Our Vaccine Carrier Proteins and Vaccine Adjuvants Include:
Tetanus Toxoid made from native tetanus toxin, produced in Clostridium tetani
Cholera Toxin B Subunit made from Vibrio cholerae
Diphtheria Toxoid CRM197, a natural genetically inactive diphtheria toxin (mutant) produced in the native host, Corynebacterium diphtheriae
Adenylate Cyclase Mutant, Recombinant from Bordetella pertussis
Pertussis Toxin Mutant, activity decreased by genetic alteration of pertussis toxin, produced in Bordetella bronchiseptica
Selected Lipopolysaccharides: #400, #401, #421, #423, #433, and #434
For a list of all of the toxoids produced by List Labs, follow the link to Toxoids.
Cholera Toxin B Subunit (Choleragenoid)
from Vibrio cholerae in Low Salt
Cholera Toxin B Subunit (Choleragenoid)
from Vibrio cholerae in Low Salt
#104
Diphtheria Toxin CRM197, Mutant
Diphtheria Toxin CRM197, Mutant
#149A
Diphtheria Toxoid, from Corynebacterium diphtheriae
Diphtheria Toxoid, from Corynebacterium diphtheriae
#151
HPT? LPS, highly purified from Bordetella
pertussis 165
HPT? LPS, highly purified from Bordetella
pertussis 165
#400
LIPID A monophosphoryl
from Salmonella minnesota R595
LIPID A monophosphoryl
from Salmonella minnesota R595
#401
LIST? HPT? from Escherichia coli O113
LIST? HPT? from Escherichia coli O113
#433
Pertussis Toxin Mutant
Pertussis Toxin Mutant
#184
Tetanus Toxoid from Clostridium tetani
Tetanus Toxoid from Clostridium tetani
#191A, #191B
ULTRA PURE LPS from Escherichia coli O111:B4
ULTRA PURE LPS from Escherichia coli O111:B4
#421
ULTRA PURE LPS from Escherichia coli O55:B5
ULTRA PURE LPS from Escherichia coli O55:B5
#423
ULTRA PURE LPS from Salmonella minnesota R595 (Re) ULTRA PURE LPS from Salmonella minnesota R595 (Re)
ULTRA PURE LPS from Salmonella minnesota R595 (Re)
#434
